Literature DB >> 24325220

Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Veronica B Perez1, Neal R Swerdlow, David L Braff, Risto Näätänen, Gregory A Light.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24325220      PMCID： PMC4043396          DOI： 10.2217/bmm.13.133

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  65 in total

1.  Veterans Health Administration vocational services for Operation Iraqi Freedom/Operation Enduring Freedom Veterans with mental health conditions.

Authors:  Elizabeth W Twamley; Dewleen G Baker; Sonya B Norman; James O E Pittman; James B Lohr; Sandra G Resnick
Journal:  J Rehabil Res Dev       Date:  2013

2.  Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity.

Authors:  Veronica B Perez; Scott W Woods; Brian J Roach; Judith M Ford; Thomas H McGlashan; Vinod H Srihari; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2013-09-16       Impact factor: 13.382

3.  Disentangling early sensory information processing deficits in schizophrenia.

Authors:  Anthony J Rissling; David L Braff; Neal R Swerdlow; Gerhard Hellemann; Yuri Rassovsky; Joyce Sprock; Marlena Pela; Gregory A Light
Journal:  Clin Neurophysiol       Date:  2012-05-18       Impact factor: 3.708

4.  Frontal and temporal sources of mismatch negativity in healthy controls, patients at onset of schizophrenia in adolescence and others at 15 years after onset.

Authors:  L B Oknina; N Wild-Wall; R D Oades; S A Juran; B Röpcke; U Pfueller; M Weisbrod; E Chan; E Y H Chen
Journal:  Schizophr Res       Date:  2004-11-11       Impact factor: 4.939

Review 5.  The mismatch negativity: a powerful tool for cognitive neuroscience.

Authors:  R Näätänen
Journal:  Ear Hear       Date:  1995-02       Impact factor: 3.570

Review 6.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

7.  Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.

Authors:  Dean F Salisbury; Noriomi Kuroki; Kiyoto Kasai; Martha E Shenton; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2007-05

8.  Mismatch negativity in chronic schizophrenia and first-episode schizophrenia.

Authors:  Dean F Salisbury; Martha E Shenton; Carlye B Griggs; Aaron Bonner-Jackson; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2002-08

9.  Reduced mismatch negativity predates the onset of psychosis.

Authors:  Madiha Shaikh; Lucia Valmaggia; Matthew R Broome; Anirban Dutt; Julia Lappin; Fern Day; James Woolley; Paul Tabraham; Muriel Walshe; Louise Johns; Paolo Fusar-Poli; Oliver Howes; Robin M Murray; Philip McGuire; Elvira Bramon
Journal:  Schizophr Res       Date:  2011-10-24       Impact factor: 4.939

10.  Auditory change detection in schizophrenia: sources of activity, related neuropsychological function and symptoms in patients with a first episode in adolescence, and patients 14 years after an adolescent illness-onset.

Authors:  Robert D Oades; Nele Wild-Wall; Stephanie A Juran; Jan Sachsse; Ljubov B Oknina; Bernd Röpcke
Journal:  BMC Psychiatry       Date:  2006-02-08       Impact factor: 3.630
View more
  15 in total

1.  Assessing the internal consistency of the event-related potential: An example analysis.

Authors:  Nina N Thigpen; Emily S Kappenman; Andreas Keil
Journal:  Psychophysiology       Date:  2017-01       Impact factor: 4.016

2.  Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia.

Authors:  William C Hochberger; Yash B Joshi; Michael L Thomas; Wendy Zhang; Andrew W Bismark; Emily B H Treichler; Melissa Tarasenko; John Nungaray; Joyce Sprock; Lauren Cardoso; Neal Swerdlow; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2018-10-30       Impact factor: 7.853

3.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 4.  Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Ann N Y Acad Sci       Date:  2015-03-09       Impact factor: 5.691

5.  Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.

Authors:  Veronica B Perez; Melissa Tarasenko; Makoto Miyakoshi; Sean T Pianka; Scott D Makeig; David L Braff; Neal R Swerdlow; Gregory A Light
Journal:  Neuropsychopharmacology       Date:  2017-01-31       Impact factor: 7.853

6.  Comparison of the heritability of schizophrenia and endophenotypes in the COGS-1 family study.

Authors:  Gregory Light; Tiffany A Greenwood; Neal R Swerdlow; Monica E Calkins; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff
Journal:  Schizophr Bull       Date:  2014-06-05       Impact factor: 9.306

7.  Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia.

Authors:  Melissa Tarasenko; Veronica B Perez; Sean T Pianka; Sophia Vinogradov; David L Braff; Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Res       Date:  2016-02-02       Impact factor: 4.939

8.  Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Authors:  Gregory A Light; Neal R Swerdlow; Michael L Thomas; Monica E Calkins; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Marlena Pela; Allen D Radant; Larry J Seidman; Richard F Sharp; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; David L Braff; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2014-10-23       Impact factor: 4.939

Review 9.  Mismatch negativity (MMN) as an index of cognitive dysfunction.

Authors:  Risto Näätänen; Elyse S Sussman; Dean Salisbury; Valerie L Shafer
Journal:  Brain Topogr       Date:  2014-05-17       Impact factor: 3.020

10.  Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia.

Authors:  Michael L Thomas; Michael F Green; Gerhard Hellemann; Catherine A Sugar; Melissa Tarasenko; Monica E Calkins; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Allen D Radant; Larry J Seidman; Alexandra L Shiluk; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff; Gregory A Light
Journal:  JAMA Psychiatry       Date:  2017-01-01       Impact factor: 21.596
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.